Download Report

Global Elastomeric Infusion Pumps Market Value is Expected to
Increase to US$ 644.0 Million By The End Of 2024
Persistence Market Research
Global Elastomeric Infusion Pumps Market
Value is Expected to Increase to US$ 644.0
Million By The End Of 2024: By PMR
Persistence Market Research
1
Global Elastomeric Infusion Pumps Market Value is Expected to
Increase to US$ 644.0 Million By The End Of 2024
Persistence Market Research Released New Market Report on “Global Elastomeric Infusion
Pumps Market Value is Expected to Increase to US$ 644.0 Million By The End Of 2024”.
Persistence Market Research (PMR) delivers key insights on the global elastomeric infusion
pumps market in its upcoming report titled, “Elastomeric Infusion Pumps Market 2016-2024”. In
terms of revenue, the global elastomeric pumps market is projected to expand at a CAGR of
5.8% during the forecast period in terms of value. The global elastomeric pumps market value is
expected to increase to US$ 644.0 million by the end of 2024.
Interested in report: Please follow the below the links to meet your requirements;
Request for the Report Sample: http://www.persistencemarketresearch.com/samples/11032
“Global Elastomeric Infusion Pumps Market: Asia Pacific to Witness Highest Growth by 2024,
Growth is expected to be driven by Favorable Reimbursement Policies for Infusion Therapy in
Homecare Settings over the Forecast Period.”
The market is segmented based on product type, treatment type, end users, and regions. Based
on product type, the market has been segmented into continuous rate elastomeric pumps and
variable rate elastomeric pumps. Variable rate elastomeric pumps segment is expected to grow
at the fastest CAGR over the forecast period, driven by increasing adoption of patient-controlled
analgesia (PCA) elastomeric pumps, i.e. elastomeric pumps with a bolus. The segment is
expected to register a significant CAGR of 6.9% during the forecast period. Whereas continuous
rate elastomeric pumps segment is anticipated to grow at CAGR of 5.1% over the forecast
period.
The market has been segmented based on different types of treatment such as pain
management, antiviral/antibiotic, chemotherapy, and chelation therapy (iron chelation for
thalassemia patients) to provide deeper insight into the pattern of demand for elastomeric
infusion pumps. The pain management segment is expected to expand at the highest CAGR of
6.7% over the forecast period.
Based on end users, the market has been segmented into hospitals, ambulatory surgical
centres, home care, clinics and, others (long-term care units, elderly care units). The hospitals
segment is anticipated to account for the highest demand for elastomeric infusion pumps over
the forecast period, registering a CAGR of 6.6% due to cost attainment models adopted by the
Persistence Market Research
2
Global Elastomeric Infusion Pumps Market Value is Expected to
Increase to US$ 644.0 Million By The End Of 2024
hospitals, increasing the demand for disposable ambulatory home infusion therapy. Secondly,
better reimbursement options for home infusion in developed economies, is expected to push
demand for elastomeric infusion pumps in home care segment over the forecast period.
View TOC (table of content), Figures and Tables of the Report:
http://www.persistencemarketresearch.com/market-research/elastomeric-Infusion-pumpsmarket/toc
A key trend in elastomeric infusion pumps market is the development of better designs for
pumps ensuring greater patient safety. In addition, it has been noted that the market is
fragmented with few established brands and many regional and local players in global
elastomeric pumps market.
Browse Full Report: http://www.persistencemarketresearch.com/market-research/elastomericInfusion-pumps-market.asp
This report assesses trends, that drive growth of each segment on the global as well as regional
levels, and offers potential takeaways, that could prove substantially useful to start-up and other
medical device manufacturing companies who wish to enter the market. North America is
expected to dominate the elastomeric infusion pumps market with the maximum market share in
2016. North America and Western Europe collectively, have been expected to account for more
than 65% of the total elastomeric infusion pump market share in terms of value in 2016. Among
emerging markets, Asia Pacific is estimated to exhibit the highest CAGR of 7.1% over the
forecast period, due to increase in the regional and local players.
To Buy this Full Report: http://www.persistencemarketresearch.com/checkout/11032
Some key players in the global elastomeric infusion pump market identified in the report include
B. Braun Melsungen AG., Fresenius Kabi AG, Baxter International Inc., Halyard Health, Inc.,
Nipro Corporation, and Woo Young Medical Co. We have discussed individual strategies of
these companies in terms of enhancing product designing, creating new manufacturing facilities,
and enhancing distribution base. The report has been concluded with strategic
recommendations for players already present in the market and new players planning to enter
the market, which could help them in the long run.
Persistence Market Research
3
Global Elastomeric Infusion Pumps Market Value is Expected to
Increase to US$ 644.0 Million By The End Of 2024
Market Bytes:
Elastomeric pumps are disposable, non-electronic medication pumps that delivers fluids such as
analgesics, antibiotics, etc. into a patient’s body in controlled amounts. The required pressure
for administrating the drug comes from the elastomeric layer existing inside the pump. Pump
failure can have significant implications on patient safety, making it mandatory for pumps to be
operated by a trained person. The global elastomeric infusion pumps market has been
segmented on the basis of product type, treatment type, end user, and regions.
Growth of the global elastomeric infusion pumps market is mainly driven by rising adoption and
growing demand for small disposable ambulatory pumps, due to its long term home care
rehabilitation program. Another prominent growth driver is the increasing number of surgeries as
a result of increasing rate of hospitalization, which ultimately increases the demand for
elastomeric pumps for post-operative pain management. However, rising R&D costs and
frequent product recalls, mostly due to design flaws, are expected to restrain growth of the
market over the forecast period.
International harmonization, along with frequent product inspections, is set to define the
regulatory landscape for elastomeric infusion pumps. Device manufacturers are expected to
invest more on better product designs to minimize the probability of product recalls and adverse
impact on patient safety.
Based on product type, the market has been segmented into continuous rate elastomeric
pumps and variable rate elastomeric pumps.
Based on treatment, the market has been segmented into pain management, antibiotic/antiviral,
chemotherapy, and chelation therapy (iron chelation). Pain management treatment segment,
followed by chemotherapy treatment segment, is expected to account for the highest demand
for elastomeric infusion pumps over the forecast period.
Based on end users, the market has been segmented into hospitals, clinics, ambulatory surgical
centres, home care, and others. Hospitals segment currently accounts for the highest revenue
of the elastomeric infusion pumps market. Home infusion therapy is also gaining prominence in
the U.S. due to upcoming attractive reimbursement options.
Persistence Market Research
4
Global Elastomeric Infusion Pumps Market Value is Expected to
Increase to US$ 644.0 Million By The End Of 2024
The global elastomeric infusion pumps market has been segmented into five major regions:
North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA). In
terms of value, North America is estimated to be the dominant market for global elastomeric
infusion pumps market in 2016 and expected to expand at a CAGR of 5.7% over the forecast
period. Europe and APAC are estimated to be the fastest growing markets in terms of CAGR.
APAC elastomeric infusion pumps market is expected to register a CAGR of 7.1% over the
forecast period. Hospitals segment in the APAC elastomeric infusion pumps market is expected
to register a CAGR of 7.9% over the forecast period, with growth driven by development of
healthcare infrastructure leading to more construction of small and mid-sized hospitals, and
increasing number of local players and start-up firms entering this market.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses
achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multidisciplinary approach. At PMR, we unite various data streams from multi-dimensional sources.
By deploying real-time data collection, big data, and customer experience analytics, we deliver
business intelligence for organizations of all sizes.
Contact
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: [email protected]
[email protected]
Web: http://www.persistencemarketresearch.com
Persistence Market Research
5